US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
US4826831A
(en)
|
1983-08-05 |
1989-05-02 |
Pre Jay Holdings Limited |
Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
|
CA1306950C
(en)
|
1987-04-10 |
1992-09-01 |
Alec D. Keith |
Buccal administration of estrogens
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
BE1003647A5
(fr)
|
1989-02-28 |
1992-05-12 |
Syntex Inc |
Composition pharmaceutique de nicardipine pour administration parenterale.
|
JPH03237557A
(ja)
|
1990-02-14 |
1991-10-23 |
Oki Electric Ind Co Ltd |
ニューラルネットワークシミュレータ及び計算機システム
|
US5340585A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Method and formulations for use in treating benign gynecological disorders
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
US5468736A
(en)
|
1993-02-25 |
1995-11-21 |
The Medical College Of Hampton Road |
Hormone replacement therapy
|
US5895783A
(en)
|
1993-07-16 |
1999-04-20 |
Schering Aktiengesellschaft |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
DE4344405C2
(de)
|
1993-12-24 |
1995-12-07 |
Marika Dr Med Ehrlich |
Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
|
AU2103495A
(en)
|
1994-08-04 |
1996-03-04 |
Biex, Inc. |
Method for prediction of premature delivery using estetrol (e4) as an indicator
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
FR2772272B1
(fr)
|
1997-12-16 |
2000-01-14 |
Rhone Poulenc Rorer Sa |
Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
|
PL197989B1
(pl)
|
1997-12-19 |
2008-05-30 |
Smithkline Beecham Corp |
Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego
|
US7815937B2
(en)
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
US6180682B1
(en)
*
|
1999-01-26 |
2001-01-30 |
Virgil A. Place |
Buccal drug delivery system for use in male contraception
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
DK1237904T3
(da)
|
1999-12-02 |
2006-06-06 |
Akzo Nobel Nv |
14,15-beta-methylensubstituerede androgener
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
DE60113809T2
(de)
|
2000-01-18 |
2006-06-22 |
Schering Ag |
Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
|
FR2809619B1
(fr)
|
2000-06-06 |
2004-09-24 |
Pharmatop |
Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
|
EP1216713A1
(en)
*
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
ATE350041T1
(de)
*
|
2001-05-18 |
2007-01-15 |
Pantarhei Bioscience Bv |
Pharmaceutishe zusammensetzung für die hormonersatztherapie
|
DE60101276T2
(de)
|
2001-05-23 |
2004-04-22 |
Pantarhei Bioscience B.V. |
Zubereitungen für die hormonale Kontrazeption
|
WO2002094277A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Means and method for hormonal contraception
|
WO2002094278A1
(en)
|
2001-05-23 |
2002-11-28 |
Pantarhei Bioscience B.V. |
Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
|
US20020193356A1
(en)
|
2001-05-23 |
2002-12-19 |
Van Beek Agatha Antonia Magdalena |
Means and method for hormonal contraception
|
PT1390042E
(pt)
|
2001-05-23 |
2008-03-10 |
Pantarhei Bioscience Bv |
Sistema de administração de um medicamento que compreende estrogénio tetrahidroxilado destinado à contracepção hormonal
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
WO2003041718A1
(en)
|
2001-11-15 |
2003-05-22 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
MEP37208A
(en)
|
2002-02-21 |
2011-02-10 |
Bayer Schering Pharma Ag |
Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12
|
US20050147670A1
(en)
*
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
DE60308679T2
(de)
|
2002-06-11 |
2007-08-16 |
Pantarhei Bioscience B.V. |
Methode zur behandlung oder prävention immunologischer erkrankungen und pharmazeutische zusammensetzung zur solchen anwendung
|
AU2003274941A1
(en)
|
2002-06-11 |
2003-12-22 |
Pantarhei Bioscience B.V. |
A method of treating human skin and a skin care composition for use in such a method
|
SI1526856T1
(sl)
|
2002-07-12 |
2008-04-30 |
Pantarhei Bioscience Bv |
Farmacevtski sestavek, ki obsega estetrolne derivate za uporabo pri zdravljenju raka
|
NZ538342A
(en)
|
2002-08-28 |
2007-08-31 |
Robert Casper |
Estrogen replacement regimen
|
EP1556058B1
(en)
|
2002-10-23 |
2007-12-12 |
Pantarhei Bioscience B.V. |
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
|
DE60330888D1
(de)
|
2002-11-05 |
2010-02-25 |
Bayer Schering Pharma Ag |
Verwendung von drospirenon zur behandlung von hypertension
|
AU2003279624A1
(en)
|
2002-11-08 |
2004-06-07 |
Pantarhei Bioscience B.V. |
Synthesis of estetrol via estrone derived steroids
|
WO2004096259A1
(en)
|
2003-04-30 |
2004-11-11 |
Debiopharm S.A. |
Methods and compositions using gonadotropin hormone releasing hormone
|
PT1624878E
(pt)
|
2003-05-22 |
2007-01-31 |
Pantarhei Bioscience Bv |
Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética
|
AU2004275470B2
(en)
|
2003-09-29 |
2010-12-02 |
Novo Nordisk Health Care Ag |
Improved stability of progestogen formulations
|
ES2482104T3
(es)
|
2003-09-29 |
2014-08-01 |
Novo Nordisk Femcare Ag |
Formulaciones HRT
|
JP3841804B2
(ja)
|
2003-10-15 |
2006-11-08 |
富士化学工業株式会社 |
口腔内速崩壊性錠剤用の組成物
|
US20050113350A1
(en)
|
2003-11-26 |
2005-05-26 |
Bernd Duesterberg |
Extended use combination comprising estrogens and progestins
|
EP1535618A1
(en)
|
2003-11-26 |
2005-06-01 |
Schering Aktiengesellschaft |
Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
|
MY151322A
(en)
|
2004-04-30 |
2014-05-15 |
Bayer Ip Gmbh |
Management of breakthrough bleeding in extended hormonal contraceptive regimens
|
GB0410616D0
(en)
|
2004-05-13 |
2004-06-16 |
Unilever Plc |
Antiperspirant or deodorant compositions
|
DE102004026670A1
(de)
|
2004-05-28 |
2005-12-15 |
Grünenthal GmbH |
Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
|
PL1755562T3
(pl)
|
2004-05-28 |
2014-03-31 |
Richter Gedeon Nyrt |
Środek antykoncepcyjny zawierający kwas foliowy
|
WO2006002937A1
(en)
|
2004-07-01 |
2006-01-12 |
Lek Pharmaceuticals D.D. |
Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose
|
UA89964C2
(ru)
|
2004-09-08 |
2010-03-25 |
Н.В. Органон |
15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
|
EA013867B1
(ru)
|
2005-02-03 |
2010-08-30 |
Никомед Фарма Ас |
Способ получения гранулята, содержащего карбонат кальция
|
JP5004236B2
(ja)
*
|
2005-02-09 |
2012-08-22 |
キッセイ薬品工業株式会社 |
口腔内崩壊錠
|
IS7724A
(is)
|
2005-03-02 |
2006-09-03 |
Actavis Group |
Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
|
UY29527A1
(es)
|
2005-05-13 |
2006-12-29 |
Schering Ag |
Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
|
JP5268635B2
(ja)
|
2005-05-26 |
2013-08-21 |
アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
17β−HSD1及びSTSインヒビター
|
BRPI0612586A2
(pt)
|
2005-06-29 |
2010-11-23 |
Wyeth Corp |
formulações de estrogênios conjugados e bazedoxifeno
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
EP1971344B1
(en)
|
2006-01-09 |
2010-09-22 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
MX2008011074A
(es)
|
2006-03-02 |
2008-09-10 |
Warner Chilcott Co Inc |
Metodo anticonceptivo oral multifasico de ciclo prolongado.
|
US20070286819A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
CN101443015A
(zh)
|
2006-06-08 |
2009-05-27 |
沃纳奇尔科特公司 |
具有改善的生物利用率的乙炔雌二醇及其药物前体的固体剂型的给药方法
|
DE112007001600A5
(de)
|
2006-07-06 |
2009-04-30 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
|
CN101489563A
(zh)
|
2006-07-06 |
2009-07-22 |
拜耳先灵医药股份有限公司 |
用于避孕和预防先天性畸形风险的药物制剂
|
US20080175905A1
(en)
|
2006-11-29 |
2008-07-24 |
Wyeth |
Estrogen/serm and estrogen/progestin bi-layer tablets
|
ES2531929T3
(es)
|
2006-12-20 |
2015-03-20 |
Teva Women's Health, Inc. |
Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
|
EP2114412B1
(en)
|
2007-01-08 |
2010-07-14 |
Pantarhei Bioscience B.V. |
Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
|
RU2009125413A
(ru)
|
2007-01-12 |
2011-02-20 |
Вайет (Us) |
Композиции таблетка-в-таблетке
|
EP1972618A1
(en)
|
2007-03-20 |
2008-09-24 |
Nabriva Therapeutics AG |
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
WO2009011576A1
(en)
|
2007-07-19 |
2009-01-22 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
FR2920311B1
(fr)
|
2007-08-31 |
2010-06-18 |
Galenix Innovations |
Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
|
JP5399749B2
(ja)
|
2008-03-27 |
2014-01-29 |
沢井製薬株式会社 |
プロトンポンプ阻害剤を含有する被覆微粒子
|
DK2262486T3
(da)
|
2008-08-01 |
2013-03-25 |
Krka Tovarna Zdravil D D Novo Mesto |
Quetiapin sammensætning
|
US20110250274A1
(en)
*
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
CN101780073B
(zh)
|
2009-01-21 |
2013-07-03 |
重庆圣华曦药业股份有限公司 |
非布司他分散片药物及其制备方法
|
KR101565621B1
(ko)
|
2009-01-26 |
2015-11-03 |
신에쓰 가가꾸 고교 가부시끼가이샤 |
저치환도 히드록시프로필셀룰로오스 수분산액을 이용한 습식 조립 타정법
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
EP2410995A1
(en)
|
2009-03-26 |
2012-02-01 |
Royal College of Surgeons in Ireland |
Orodispersible tablets
|
ITMI20091109A1
(it)
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
AU2010265180B2
(en)
|
2009-06-23 |
2014-09-11 |
Bayer Intellectual Property Gmbh |
Pharmaceutical composition for emergency contraception
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
JP5945267B2
(ja)
|
2010-04-12 |
2016-07-05 |
ユニヴェルシテ クロード ベルナール リヨン 1 |
有機ケイ素ゾルの急速縮合によって得られるハイブリッド材料の製造方法
|
US20130137664A1
(en)
|
2010-04-15 |
2013-05-30 |
Bayer Intellectual Property Gmbh |
Low-dosed solid oral dosage forms for hrt
|
EP2399904A1
(en)
|
2010-05-26 |
2011-12-28 |
Nabriva Therapeutics AG |
Process for the preparation of pleuromutilins
|
AR081670A1
(es)
|
2010-06-29 |
2012-10-10 |
Leon Farma Sa Lab |
Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
|
US10849857B2
(en)
|
2010-07-28 |
2020-12-01 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
WO2012055840A1
(en)
|
2010-10-28 |
2012-05-03 |
Bayer Pharma Aktiengesellschaft |
Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
|
KR101965002B1
(ko)
|
2010-12-02 |
2019-08-13 |
아데어 파마슈티컬스 인코포레이티드 |
급속 분산성 과립, 구강 붕해성 정제 및 방법
|
JP2012240917A
(ja)
|
2011-05-16 |
2012-12-10 |
Zensei Yakuhin Kogyo Kk |
製剤化用微粒子とそれを含む製剤
|
EA023991B1
(ru)
|
2011-06-01 |
2016-08-31 |
Эстетра С.П.Р.Л. |
Способ получения интермедиатов эстетрола
|
HUE031809T2
(en)
|
2011-06-01 |
2017-08-28 |
Estetra Sprl |
Process for the preparation of estetrol intermediates
|
EP2383279A1
(en)
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
EP2734193B1
(en)
|
2011-07-19 |
2015-05-20 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (dhea)
|
SI2741824T1
(sl)
*
|
2011-08-11 |
2017-06-30 |
Estetra S.P.R.L. |
Uporaba estetrola kot urgentnega kontracepcijskega sredstva
|
JP6174585B2
(ja)
|
2011-09-16 |
2017-08-02 |
フェリング ベスローテン フェンノートシャップ |
速溶性医薬組成物
|
US8987484B2
(en)
|
2011-10-07 |
2015-03-24 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
DE202012012822U1
(de)
|
2011-12-13 |
2014-02-03 |
Arstat, Inc. |
Empfängnisverhütungs-Set zur aufeinanderfolgenden täglichen Anwendung
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
US9238265B2
(en)
|
2012-09-27 |
2016-01-19 |
General Electric Company |
Backstrike protection during machining of cooling features
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
JP6126456B2
(ja)
|
2013-05-17 |
2017-05-10 |
東和薬品株式会社 |
打錠用顆粒とその製造方法、その打錠用顆粒を用いた口腔内崩壊錠
|
US20140341326A1
(en)
|
2013-05-20 |
2014-11-20 |
Qualcomm Incorporated |
Channel estimation with discontinuous pilot signals
|
BR112015029056A2
(pt)
|
2013-05-21 |
2017-07-25 |
Predictive Therapeutics Llc |
composto, e pílula farmacêutica ou pastilha implantável por via subcutânea para tratar um ser humano que sofre de endometriose
|
ES2624667T3
(es)
|
2013-09-18 |
2017-07-17 |
Crystal Pharma, S.A.U. |
Procedimiento para la preparación de estetrol
|
US20150098978A1
(en)
|
2013-10-03 |
2015-04-09 |
Altria Client Services Inc. |
Dissolvable-chewable tablet
|
CN105939704A
(zh)
*
|
2013-12-04 |
2016-09-14 |
盖尔德马研究及发展公司 |
优选包含类维生素a的脂质微胶囊以及含有其的组合物、制造其的方法及其在皮肤病学中的用途
|
US9884064B2
(en)
*
|
2013-12-12 |
2018-02-06 |
Donesta Bioscience B.V. |
Orally disintegrating solid dosage unit containing an estetrol component
|
US10571371B2
(en)
|
2014-08-07 |
2020-02-25 |
Wake Forest University Health Sciences |
Compositions and methods for clearing a biological sample
|
CA2962921A1
(en)
|
2014-09-29 |
2016-04-07 |
The Regents Of The University Of California |
Compositions and methods for maintaining cognitive function
|
BR112017024783A2
(pt)
|
2015-05-18 |
2018-08-07 |
Agile Therapeutics Inc |
composições contraceptivas e métodos para eficácia melhorada e modulação dos efeitos colaterais
|
CN107771075A
(zh)
|
2015-06-18 |
2018-03-06 |
密特拉制药公司 |
含雌四醇组分的口腔分散剂量单位
|
HUE054589T2
(hu)
|
2015-06-18 |
2021-09-28 |
Estetra Sprl |
Szájban diszpergálódó esztetrol tartalmú tabletta
|
WO2016203006A1
(en)
|
2015-06-18 |
2016-12-22 |
Mithra Pharmaceuticals S.A. |
Orodispersible dosage unit containing an estetrol component
|
LT3310346T
(lt)
|
2015-06-18 |
2021-06-10 |
Estetra Sprl |
Burnoje disperguojama tabletė, turinti estetrolio
|
JP6827962B2
(ja)
|
2015-06-23 |
2021-02-10 |
ラボラトリオス レオン ファーマ エスエー |
過剰体重に影響される女性患者のためのドロスピレノン系避妊薬
|
CA3178291A1
(en)
|
2016-08-05 |
2018-04-12 |
Estetra Srl |
Method for the management of dysmenorrhea and menstrual pain
|
US20200046729A1
(en)
|
2016-08-05 |
2020-02-13 |
Estetra Sprl |
Methods using combined oral contraceptive compositions with reduced cardiovascular effects
|
CA3041016C
(en)
|
2016-10-28 |
2023-09-05 |
Estetra Sprl |
Method for the management of dysmenorrhea and menstrual pain
|
AU2019219070A1
(en)
|
2018-02-07 |
2020-09-24 |
Estetra Srl |
Contraceptive composition with reduced cardiovascular effects
|
TWI801561B
(zh)
|
2018-04-19 |
2023-05-11 |
比利時商依思特拉私人有限責任公司 |
化合物及其用於緩解絕經相關症狀的用途
|
JOP20200260A1
(ar)
|
2018-04-19 |
2019-10-19 |
Estetra Sprl |
مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
|
US10929286B2
(en)
|
2018-06-29 |
2021-02-23 |
Seagate Technology Llc |
Arbitrated management of a shared non-volatile memory resource
|
TW202203935A
(zh)
|
2020-04-16 |
2022-02-01 |
比利時商埃斯特拉有限責任公司 |
具有降低之副作用之避孕組成物
|